AUPO933597A0 - Diagnostic method - Google Patents

Diagnostic method

Info

Publication number
AUPO933597A0
AUPO933597A0 AUPO9335A AUPO933597A AUPO933597A0 AU PO933597 A0 AUPO933597 A0 AU PO933597A0 AU PO9335 A AUPO9335 A AU PO9335A AU PO933597 A AUPO933597 A AU PO933597A AU PO933597 A0 AUPO933597 A0 AU PO933597A0
Authority
AU
Australia
Prior art keywords
diagnostic method
diagnostic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO9335A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRC for Biopharmaceutical Research Pty Ltd
Original Assignee
CRC for Biopharmaceutical Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRC for Biopharmaceutical Research Pty Ltd filed Critical CRC for Biopharmaceutical Research Pty Ltd
Priority to AUPO9335A priority Critical patent/AUPO933597A0/en
Publication of AUPO933597A0 publication Critical patent/AUPO933597A0/en
Priority to PCT/AU1998/000788 priority patent/WO1999015902A1/en
Priority to AU91472/98A priority patent/AU9147298A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AUPO9335A 1997-09-22 1997-09-22 Diagnostic method Abandoned AUPO933597A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPO9335A AUPO933597A0 (en) 1997-09-22 1997-09-22 Diagnostic method
PCT/AU1998/000788 WO1999015902A1 (en) 1997-09-22 1998-09-22 Diagnostic method for detecting soluble cd48
AU91472/98A AU9147298A (en) 1997-09-22 1998-09-22 Diagnostic method for detecting soluble cd48

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO9335A AUPO933597A0 (en) 1997-09-22 1997-09-22 Diagnostic method

Publications (1)

Publication Number Publication Date
AUPO933597A0 true AUPO933597A0 (en) 1997-10-09

Family

ID=3803617

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO9335A Abandoned AUPO933597A0 (en) 1997-09-22 1997-09-22 Diagnostic method

Country Status (2)

Country Link
AU (1) AUPO933597A0 (en)
WO (1) WO1999015902A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409565B2 (en) * 2006-02-14 2013-04-02 Francesca Levi-Schaffer Therapeutic target and diagnostic marker for asthma and related conditions
EP2418222B1 (en) * 2009-04-10 2016-11-02 Osaka University Therapeutic agent for treating diseases in which neoplastic proliferation of plasma cells occurs

Also Published As

Publication number Publication date
WO1999015902A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
AU696462B2 (en) Diagnostic method
AU6686298A (en) Distributed diagnostic system
GB9607287D0 (en) Diagnosis method
AU6105199A (en) Diagnostic method
GB9603031D0 (en) Diagnostic method
AU2183997A (en) New method
AU3704297A (en) Method
AU7823694A (en) Imaging method
AUPO935597A0 (en) Improved fastening method
AUPN058895A0 (en) Diagnostic method
AUPO870297A0 (en) Method
AUPO937097A0 (en) Method
GB9704876D0 (en) Diagnostic methods
AU6000600A (en) Diagnostic method
AU2194801A (en) Diagnostic method
AU1984900A (en) Diagnostic method
AUPP612798A0 (en) Diagnostic method
AUPO933597A0 (en) Diagnostic method
AUPM701594A0 (en) Diagnostic method
AUPN192695A0 (en) Diagnosis method
AUPO936697A0 (en) Diagnostic method
AUPO109796A0 (en) Construction method
AUPO245596A0 (en) Diagnostic method
AU3776697A (en) Method
AU2973095A (en) Diagnostic method